Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 36% ± 19% | |
endothelial cell | 16 studies | 28% ± 13% | |
microglial cell | 12 studies | 42% ± 17% | |
fibroblast | 11 studies | 23% ± 4% | |
type I pneumocyte | 8 studies | 35% ± 9% | |
oligodendrocyte | 8 studies | 25% ± 8% | |
GABAergic neuron | 7 studies | 34% ± 14% | |
oligodendrocyte precursor cell | 7 studies | 29% ± 10% | |
retina horizontal cell | 6 studies | 60% ± 24% | |
smooth muscle cell | 6 studies | 19% ± 2% | |
type II pneumocyte | 5 studies | 22% ± 5% | |
interneuron | 5 studies | 34% ± 11% | |
retinal pigment epithelial cell | 4 studies | 44% ± 24% | |
mesothelial cell | 4 studies | 42% ± 12% | |
glutamatergic neuron | 4 studies | 31% ± 17% | |
macrophage | 3 studies | 22% ± 5% | |
epithelial cell | 3 studies | 26% ± 8% | |
Mueller cell | 3 studies | 19% ± 3% | |
rod bipolar cell | 3 studies | 25% ± 7% | |
basal cell | 3 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 19% ± 3% | |
connective tissue cell | 3 studies | 22% ± 7% | |
ependymal cell | 3 studies | 46% ± 15% | |
capillary endothelial cell | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1682.50 | 2638 / 2642 | 100% | 18.35 | 702 / 705 |
prostate | 100% | 2136.64 | 244 / 245 | 98% | 16.28 | 490 / 502 |
kidney | 100% | 1797.17 | 89 / 89 | 95% | 12.85 | 853 / 901 |
adrenal gland | 100% | 2497.66 | 258 / 258 | 91% | 13.54 | 210 / 230 |
thymus | 99% | 1423.11 | 649 / 653 | 91% | 9.57 | 553 / 605 |
breast | 100% | 2195.62 | 458 / 459 | 90% | 14.47 | 1008 / 1118 |
lung | 100% | 2684.03 | 577 / 578 | 84% | 10.39 | 969 / 1155 |
skin | 83% | 1975.63 | 1501 / 1809 | 95% | 24.05 | 447 / 472 |
ovary | 100% | 3590.63 | 180 / 180 | 72% | 10.40 | 310 / 430 |
uterus | 99% | 3897.18 | 169 / 170 | 69% | 9.66 | 315 / 459 |
bladder | 100% | 2389.52 | 21 / 21 | 63% | 5.66 | 316 / 504 |
esophagus | 80% | 1969.80 | 1156 / 1445 | 75% | 9.79 | 138 / 183 |
pancreas | 54% | 372.28 | 178 / 328 | 92% | 10.60 | 163 / 178 |
intestine | 85% | 2481.18 | 817 / 966 | 37% | 3.27 | 195 / 527 |
stomach | 62% | 1324.05 | 223 / 359 | 51% | 4.57 | 145 / 286 |
adipose | 100% | 2745.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3176.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1880.72 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 1581.69 | 807 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 6.56 | 32 / 45 |
spleen | 66% | 472.93 | 159 / 241 | 0% | 0 | 0 / 0 |
liver | 28% | 167.53 | 64 / 226 | 37% | 4.12 | 149 / 406 |
eye | 0% | 0 | 0 / 0 | 65% | 4.80 | 52 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.26 | 2 / 29 |
peripheral blood | 0% | 1.09 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
Gene name | RASSF8 |
Protein name | Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1) Ras association domain family member 8 |
Synonyms | C12orf2 |
Description | |
Accessions | F5H8C5 ENST00000381352.7 [Q8NHQ8-2] ENST00000689434.1 [Q8NHQ8-1] ENST00000545413.1 ENST00000615708.4 [Q8NHQ8-2] ENST00000282884.13 [Q8NHQ8-1] Q8NHQ8 ENST00000541218.5 ENST00000537946.5 F5H8B9 F5H0S5 ENST00000689635.1 [Q8NHQ8-1] H0YG85 ENST00000539545.1 ENST00000688511.1 [Q8NHQ8-1] ENST00000542004.5 ENST00000542865.5 [Q8NHQ8-1] F5H7J1 ENST00000541490.5 [Q8NHQ8-1] ENST00000535907.5 F5GYP8 ENST00000405154.6 [Q8NHQ8-1] F5H343 ENST00000542315.5 |